A Fresh Take on Rosacea: Triggers, Comorbidities & Cutting-Edge Treatments
ODAC Co-Chair Dr. Adam Friedman says some nuanced changes in recently published scientific literature have changed the way he approaches rosacea. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Friedman, who addressed the latest understanding of rosacea triggers. Should your still tell your rosacea patients to avoid coffee? Find out what the latest researc …
ODAC Co-Chair Dr. Adam Friedman says some nuanced changes in recently published scientific literature have changed the way he approaches rosacea. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Friedman, who addressed the latest understanding of rosacea triggers. Should your still tell your rosacea patients to avoid coffee? Find out what the latest researc … Continue reading "A Fresh Take on Rosacea: Triggers, Comorbidities & Cutting-Edge Treatments"
At the 2025 Pigmentary Disorders Exchange Symposium, Dr. Rebecca Vasquez, Associate Professor of Dermatology at UT Southwestern Medical Center, delivered an insightful presentation on drug-induced causes of hyperpigmentation. Her talk focused on the pathophysiology, clinical evaluation, and diagnostic tools used to differentiate these disorders from more common pigmentary conditions such as melasm … 
A paradigm shift in the understanding of melasma is changing the way dermatology clinicians approach the condition. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Mukta Sachdev, head of the department of dermatology at Manipal Hospital, Bangalore, India. Watch as Dr. Sachdev shares why photoprotection, barrier function, and pollution are some of the factor … 
Secukinumab is a recombinant human monoclonal immunoglobulin IgG1κ antibody that selectively targets interleukin-17A (IL-17A), a key effector cytokine in the Th17 pathway implicated in the pathogenesis of psoriasis. With its high target specificity, rapid onset, sustained efficacy, and favorable safety profile, secukinumab has become a mainstay in the treatment of psoriasis and other inflammatory … 
While the importance of wearing sunscreen is often emphasized, rarely do we stop to consider how sunscreen works and why it is effective. A thorough understanding of these details is essential for dermatologists and trainees alike to feel confident navigating conversations with patients about sunscreen formulations, efficacy, and safety. At the inaugural Lab to Label Conference, Dr. Candrice Heath … 